$WALD

Waldencast plc (WALD): Financial results for H1 2026

Waldencast plc (WALD) furnished an SEC Form 6-K — earnings release. Exhibit 99.1 Waldencast plc Announces First Half 2026 Financial Results September 28, 2026 – New York, New York – Waldencast plc (NASDAQ: WALD) (“Waldencast” or the “Company”), the parent company of Milk Makeup, the clean prestige beauty brand born from the creative community of

Original reporting
Published Sep 28, 2026, 8:30 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 28, 2026, 8:46 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$WALD
Bearish
medium confidence
Mentioned
$WALD
Relevance
7/10
AlphAI data visualization · based on SEC EDGAR 6-K
Decision brief

The 30-second read

$WALDBearishLow
01

Why it matters

The earnings release signals a steep decline in operating performance, prompting likely short‑term price weakness.

02

Market read

Primary earnings disclosure for a small‑cap listed company; relevant for traders monitoring niche consumer‑goods stocks.

03

What to watch

Potential upside from the upcoming Milk Makeup product relaunch and reduced overhead costs.

Relevance 7/10Novelty 8/10Timing: post‑market release

Background

Waldencast plc (NASDAQ: WALD) is a beauty company owning Milk Makeup, recently divested its Obagi Medical business.

Company-level read

Ticker impact

$WALDBearishMedium confidence
Context

Waldencast disclosed H1 2026 results with net revenue down 57% YoY and a net loss of $94.9 million, plus the sale of Obagi Medical for $149.9 million.

Expected impact

downward pressure as investors price in weaker performance and debt repayment.

Evidence & confidence

The sharp revenue drop and loss, combined with a delisting plan, suggest reduced investor confidence.

Market effects

Highlights challenges in the prestige beauty segment and may affect peers with similar exposure.

Limited to U.S. and UK investors; no broader market effect.

Minimal global impact beyond niche beauty investors.

Counterpoint

The cash proceeds and debt repayment could enable a turnaround if the brand execution improves.

Key entities

  • Waldencast plc

    Parent company of Milk Makeup, listed on NASDAQ.

  • Bridgepoint

    Acquired Obagi Medical from Waldencast.

Related articles

$CLFMed

Cliffs (CLF) Q3 2026 Earnings Call Transcript

Cleveland Cliffs (CLF) reported strong Q3 2026 earnings, citing favorable trade policies and successful contract renewals. The company expects over $1 billion in EBITDA improvement year-over-year. CLF is postponing a furnace reline and investing $1 billion in modernizing Middletown Works, with $500 million in DOE support. The company also discussed challenges faced by Stelco in Canada due to import competition.

$LULUHighAI 8/10

Is Lululemon's Next Big Thing Already Here?

Lululemon (LULU) reported a 20% decline in legging sales for the quarter ended August 2, 2026, while looser-fitting styles gained traction. Revenue fell 4.3% to $2.42 billion, with women's products down 4%. Management expects fiscal 2026 revenue of $10.35B-$10.5B, a 5-7% decline from 2025. The stock is down 53% from 2025, trading at 7.7x earnings.

$FITBHighAI 8/10

What Fifth Third Bancorp (FITB) Said on Its Q3 Earnings Call

Fifth Third Bancorp (FITB) reported Q3 earnings, with net interest income rising to $2.28B. The bank expects 2026 profitability to meet or exceed targets. Loans grew 1% to $180B, while deposits increased 3% to $236B. Fifth Third plans Texas expansion and launched Innovation Banking, aiming for $10B in deposits by 2030. Credit quality remained stable, and the company raised its dividend 5%.

$CMGMed

Chipotle Q3 Preview: Promos Could Push Comp Positive Despite Food-Safety Drag, Says Bullish Analyst - Chi

Chipotle (CMG) is set to report Q3 earnings on Oct. 28. BofA Securities expects sales recovery, with same-store sales raised to 1% due to promotions offsetting food-safety issues. Analyst Sara Senatore maintains a Buy rating and $53 price target, citing resilient traffic and digital activations. Revenue estimate raised to $13.05B, EPS unchanged at $1.16.

$VFSMedAI 8/10

VinFast reports $1.2 bn Q2 continuing loss despite sales jump

VinFast, a NASDAQ-listed Vietnamese EV maker, reported a $1.24 billion Q2 loss despite a 96% year-over-year increase in EV deliveries and a 311% rise in e-scooter and e-bike deliveries. The loss was partially offset by a $1.47 billion gain from selling a manufacturing subsidiary. International markets contributed only 11% of total deliveries.